Neuropsychopharmacology
- Retraction Note: Association between neuromelanin-sensitive MRI signal and psychomotor slowing in late-life depression2 years ago
- Altered excitatory and inhibitory ionotropic receptor subunit expression in the cortical visuospatial working memory network in schizophrenia2 years ago
- Does acute cannabidiol (CBD) use impair performance? A meta-analysis and comparison with placebo and delta-9-tetrahydrocannabinol (THC)2 years ago
- Kappa-opioid receptor stimulation in the nucleus accumbens shell and ethanol drinking: Differential effects by rostro-caudal location and level of drinking2 years ago
- Protective effect of PDE4B subtype-specific inhibition in an App knock-in mouse model for Alzheimer’s disease2 years ago
- Adolescent nicotine exposure induces long-term, sex-specific disturbances in mood and anxiety-related behavioral, neuronal and molecular phenotypes in the mesocorticolimbic system2 years ago
- Dorsal CA3 overactivation mediates witnessing stress-induced recognition memory deficits in adolescent male mice2 years ago
Journal of Psychopharmacology
- Cevimeline co-treatment attenuates olanzapine-induced metabolic disorders via modulating hepatic M3 muscarinic receptor: AMPKα signalling pathway in female rats5 years ago
- Neuropsychological performance in young adults with cannabis use disorder5 years ago
- A narrative synthesis of research with 5-MeO-DMT5 years ago
- Translational psychopharmacology5 years ago
- Insufficiency of ventral hippocampus to medial prefrontal cortex transmission explains antidepressant non-response5 years ago
- Accuracy in recognising happy facial expressions is associated with antidepressant response to a NOP receptor antagonist but not placebo treatment5 years ago
- Voluntary oral methamphetamine increases memory deficits and contextual sensitization during abstinence associated with decreased PKMζ and increased κOR in the hippocampus of female mice5 years ago
European Neuropsychopharmacology
- Social Stress in Bipolar Disorder4 years ago
- Comparative studies of psychotropic drug use over the last seven decades: Gaps and goals in global ethnopsychopharmacology4 years ago
- Evaluating study designs and treatment outcomes of antidepressant pharmacogenetic clinical trials – Challenges and future perspectives. A critical review4 years ago
- Cannabidiol enhancement of exposure therapy in treatment refractory patients with social anxiety disorder and panic disorder with agoraphobia: A randomised controlled trial4 years ago
- The transition from adolescence to adulthood in patients with schizophrenia: Challenges, opportunities and recommendations4 years ago
- Letter to the editor about the article “Psychiatric disorders in post-acute COVID-syndrome 3 (PDPACS): Recommendations for health care professionals” (Falconi A et al., 2022)4 years ago
- Depression, antidepressants, and insulin resistance: which link?4 years ago